Category: ABNORML NEWS

Update: Federal Judge Reserves Decision After Hearing Arguments In Washington, et.al v. Sessions

Today, Judge Alvin K. Hellerstein of the U.S. District Court for the Southern District of New York heard oral arguments on the motion to dismiss Washington, et.al v. Sessions, et.al, a federal lawsuit challenging the constitutionality of the Schedule I classification of cannabis under the Controlled Substances Act. The federal government argued to have the case dismissed. Judge Alvin K. Hellerstein of the U.S. District Court Southern District of New York reserved the decision. 

2017: A NORML Year in America

In the wake of landmark cannabis victories in 2016, there was much momentum to build upon when state legislatures opened up at the beginning of 2017. With NORML chapters in nearly all 50 states, activists took the fight to the halls of state capitals and city councils from Florida to Washington State and everywhere in between. In all, lawmakers in 26 states have passed legislation to advance cannabis reform.

Talk About Marijuana At Thanksgiving This Year

We have much to be thankful for this year. Lawmakers in 26 states have passed legislation to advance cannabis reform, including New Hampshire becoming the 22nd state to decriminalize marijuana and West Virginia becoming the 30th state to pass a medical marijuana program.

Legalization Alone is Not Enough, How We Create A New Market Matters

In March of this year, Oakland City Council implemented the Equity Permit Program for aspiring marijuana entrepreneurs in the new green economy. This program is designed to address the past disparities in the cannabis industry by giving priority to the victims of the war on drugs and minimizing barriers to entry into the industry; ultimately trying to level the playing field within the medical cannabis arena.

Legalization Alone is Not Enough, How We Create A New Market Matters

In March of this year, Oakland City Council implemented the Equity Permit Program for aspiring marijuana entrepreneurs in the new green economy. This program is designed to address the past disparities in the cannabis industry by giving priority to the victims of the war on drugs and minimizing barriers to entry into the industry; ultimately trying to level the playing field within the medical cannabis arena.